The Organ Preservation Market is becoming increasingly important as transplant programs focus not only on increasing the number of available organs but also on improving the usability and quality of donated organs. Advances in preservation solutions, machine perfusion, organ transport systems, and viability assessment technologies are helping transplant centers manage organs that may previously have been considered unsuitable for transplantation.
Market Research Future estimates that the global Organ Preservation Market was valued at approximately USD 358.6 million in 2025. The market is projected to reach about USD 382.6 million in 2026 and USD 685.8 million by 2035, expanding at a CAGR of 6.7% during the forecast period. North America currently represents the largest regional market, while Asia-Pacific is expected to record the fastest growth.
Get Free Sample PDF Brochure:
https://www.marketresearchfuture.com/sample_request/6073
Market Drivers
Growing Need for Organ Transplantation
The increasing prevalence of kidney failure, liver disease, cardiovascular disorders, and other conditions requiring transplantation is creating sustained demand for organ preservation technologies. As transplant waiting lists remain substantial in many countries, healthcare systems are looking for ways to increase the number of viable organs obtained from available donors. Improved preservation can extend the usable time of organs and support better coordination between procurement and transplant centers.
Increasing Adoption of Machine Perfusion
Machine perfusion is one of the most important technological developments influencing the Organ Preservation Market. Unlike conventional cold storage, perfusion technologies can maintain an organ under controlled conditions and, in some cases, provide information about its functional viability before transplantation.
Static Cold Storage still accounted for the largest share of the market in 2025, at approximately 52.4%. However, Normothermic Machine Perfusion is identified as the fastest-growing preservation technique, with a projected CAGR of 9.8%.
Expansion of Donation After Circulatory Death Programs
Donation after circulatory death is expanding across several established transplant markets. These organs can present additional preservation challenges because of warm ischemic exposure. Machine perfusion and advanced preservation approaches can help transplant teams manage these challenges and potentially increase organ utilization.
The increasing use of DCD organs is therefore creating new opportunities for preservation-device manufacturers and suppliers of specialized solutions and transport systems.
Improvements in Transplant Infrastructure
Investment in transplant centers, organ procurement organizations, donor registries, and specialized logistics networks is strengthening market development. Emerging healthcare markets are also increasing their transplantation capabilities, creating opportunities for preservation solution suppliers and manufacturers of advanced perfusion equipment.
Asia-Pacific is particularly important because its transplant infrastructure is expanding from a comparatively lower base. The region is projected to achieve the highest regional growth rate, at about 8.9%.
Market Challenges
High Cost of Advanced Preservation Systems
Machine perfusion systems require significant capital investment and ongoing expenditure for disposables, maintenance, training, and technical support. These costs can make adoption difficult for smaller transplant centers and healthcare systems with limited budgets.
Reimbursement Differences
Reimbursement policies vary considerably between countries and healthcare systems. Where hospitals can recover preservation and perfusion expenses through established reimbursement mechanisms, adoption can progress more rapidly. In markets where hospitals must absorb these expenses directly, investment decisions may take considerably longer.
Limited Donor Availability
Preservation technologies can improve the utilization of donated organs, but they cannot independently solve the underlying shortage of donors. The overall number of available organs remains dependent on donation rates, consent frameworks, referral systems, and transplant infrastructure.
Training and Workflow Requirements
Introducing machine perfusion requires transplant teams to modify established recovery and allocation workflows. Staff may need specialized training, while hospitals must establish procedures for device operation, organ monitoring, transportation, and emergency support.
Browse In-depth Market Research Report on Organ Preservation:
Organ Preservation Market Research Report
Market Segmentation
By Preservation Technique
The market can be divided into Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and other preservation approaches.
Static Cold Storage remains the most widely used technique because it is comparatively simple, economical, and well established. In contrast, Normothermic Machine Perfusion is gaining momentum because it allows organs to be maintained under conditions closer to normal physiological functioning and can support viability assessment.
Hypothermic Machine Perfusion also represents an important segment, particularly for kidney preservation. MRFR estimates that HMP generated approximately USD 108.2 million in revenue in 2025.
By Preservation Solution
Key preservation solutions include University of Wisconsin Solution, Custodiol HTK, Celsior, Perfadex, and other specialized formulations.
University of Wisconsin Solution represented approximately 38.6% of the preservation-solution segment in 2025. Custodiol HTK is also widely used because of its characteristics in cardiac and multi-organ applications, while Celsior and Perfadex have established roles in thoracic and lung preservation.
By Product Type
The product segment includes preservation solutions, machine perfusion systems, and transport and storage consumables.
Preservation solutions accounted for approximately 46.3% of the market in 2025. At the same time, machine perfusion systems are expected to experience strong expansion, supported by increasing adoption of advanced preservation technologies and recurring demand for procedure-specific consumables.
By Organ Type
The Organ Preservation Market covers kidneys, liver, heart, lungs, pancreas, and other organs.
Kidneys represented the largest organ category, accounting for approximately 41.2% of revenue in 2025. Liver preservation is expected to expand at an 8.1% CAGR as viability assessment and normothermic preservation become more common. Heart and lung preservation are also gaining attention because of advances in DCD transplantation and ex-vivo organ reconditioning.
By End User
Based on end user, the market includes transplant centers, hospitals, organ procurement organizations, research institutes, and specialty clinics.
Transplant centers generated approximately USD 160.7 million in 2025 and remain the most important purchasing environment because preservation technology is directly connected to transplantation procedures. Organ procurement organizations are another important growth area as healthcare authorities place greater emphasis on improving organ recovery and utilization.
Regional Insights
North America
North America held approximately 41.5% of the global Organ Preservation Market in 2025. The region benefits from high transplant volumes, established reimbursement mechanisms, sophisticated transplant infrastructure, and growing adoption of machine perfusion technologies.
The United States represents the largest market within the region, supported by its substantial transplant activity and continued investment in organ procurement and preservation infrastructure.
Europe
Europe represents the second-largest regional market, with revenue of approximately USD 99.7 million in 2025. Strong organ donation frameworks, cross-border allocation systems, established transplant networks, and growing use of advanced preservation techniques are supporting market development.
Countries such as Spain, the United Kingdom, Germany, France, and Italy remain important markets because of their established transplantation systems and ongoing efforts to increase organ utilization.
Asia-Pacific
Asia-Pacific is projected to be the fastest-growing regional market, with an estimated CAGR of 8.9%. Growing healthcare expenditure, expansion of transplant centers, development of donor registries, and increasing awareness of organ donation are creating significant opportunities.
India, China, Japan, South Korea, Australia, and other countries are investing in transplant infrastructure. India in particular represents a substantial long-term opportunity as healthcare providers expand transplantation capacity and efforts continue to improve deceased-donor utilization.
South America
South America is supported by national transplantation programs and public healthcare systems. Brazil represents the largest market in the region, while Argentina, Colombia, and Chile are also developing their transplantation infrastructure.
Public funding and centralized procurement can create consistent demand for preservation solutions, although the relatively high cost of advanced perfusion systems can limit adoption.
Middle East & Africa
The Middle East and Africa represent a smaller portion of the global market but offer long-term growth potential. Saudi Arabia and the UAE are developing sophisticated transplantation and medical tourism infrastructure, while other countries are gradually strengthening national organ donation frameworks.
Investment in tertiary healthcare facilities and specialized transplant centers should support demand for organ preservation products over the coming years.
Key Players
Major companies and organizations active in the Organ Preservation Market include:
XVIVO Perfusion AB
TransMedics Group
Organ Recovery Systems
Bridge to Life Ltd.
OrganOx Ltd.
Paragonix Technologies
Institut Georges Lopez
Preservation Solutions Inc.
BioLife Solutions
Waters Medical Systems
21st Century Medicine
These companies compete through preservation solutions, machine perfusion platforms, organ transport technologies, clinical evidence, consumables, and integrated services. MRFR identifies XVIVO Perfusion and TransMedics among the leading participants, while companies such as Organ Recovery Systems and Bridge to Life maintain significant positions across preservation and perfusion categories.
Future Outlook
The future of the Organ Preservation Market is expected to move beyond conventional storage toward technologies that actively evaluate, protect, and potentially repair organs before transplantation. Machine perfusion will remain a central area of development as transplant centers seek to make greater use of extended-criteria and DCD organs.
Viability assessment is another promising area. Perfusion systems can generate information such as metabolic activity, vascular resistance, and other physiological measurements, helping clinicians make more informed decisions about whether an organ should be transplanted.
Ex-vivo organ therapy could further broaden the market by allowing drugs, antiviral treatments, or other therapeutic approaches to be administered to organs before implantation. Research into xenotransplantation may also create demand for specialized preservation protocols and equipment in the longer term.
Overall, the Organ Preservation Market is expected to benefit from rising transplant requirements, machine perfusion adoption, improvements in donor-organ utilization, and increasing investment in transplantation infrastructure. The market is projected to grow from USD 358.6 million in 2025 to USD 685.8 million by 2035 at a CAGR of 6.7%, with Asia-Pacific providing particularly strong expansion opportunities.
Related Report:
Understand industry shifts with well-researched analysis:
Asia Pacific Diabetes Pen Market Trends
Regulatory Reporting and Compliance Market Growth
Norovirus Treatment Market Volume
Psilocybin Assisted Therapy Market Forecast
About Market Research Future:
Market Research Future (MRFR) is a global market research and business consulting organization providing research reports, industry analysis, market forecasts, and strategic insights across healthcare, technology, chemicals, energy, and other industries. Its research combines market intelligence and analytical approaches to help organizations understand market dynamics, competitive developments, emerging opportunities, and future growth prospects.
Follow Us:
Stay connected with Market Research Future for market intelligence, industry updates, research insights, and emerging technology trends.
Contact:
Market Research Future
Market Research Reports & Consulting
Healthcare and Life Sciences Market Intelligence
